No posts to display
Top News
FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means...
Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.
- Our Sponsors Ad -